Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 16, 2017 · 10-K · 75 days after period end · 0001171843-17-001555
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Net Income | -$6.96M | -$6.34M | $7.23M | -$2.40M |
| EPS Diluted | -$0.42 | -$0.38 | $0.48 | -$16.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 16, 2017 · 75 d after period end
